Evonik Industries

Evonik Industries

Develops speciality chemicals .

Launch date
Employees
Market cap
$10.1b
Enterprise valuation
$13.7b (Public information from Sep 2024)
Essen Nordrhein-Westfalen (HQ)
Corporate Venture Fund: Evonik Venture Capital

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2020202120222023202420252026
Revenues12.2b15.0b18.5b15.3b15.3b15.7b16.3b
% growth(7 %)23 %24 %(17 %)1 %2 %4 %
EBITDA1.9b2.3b3.0b1.8b2.1b2.2b2.4b
% EBITDA margin16 %15 %16 %12 %14 %14 %14 %
Profit465m746m540m(465m)498m714m802m
% profit margin4 %5 %3 %(3 %)3 %5 %5 %
EV / revenue1.3x1.1x0.6x0.8x0.8x0.8x0.7x
EV / EBITDA8.3x7.0x3.9x6.7x6.0x5.5x5.1x
R&D budget433m464m460m443m---
R&D % of revenue4 %3 %2 %3 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-

€2.4b

Buyout

N/A

Buyout
N/A

N/A

IPO

AUD49.1k

Grant
*

€500m

Post IPO Debt
Total Funding$31.8k

Recent News about Evonik Industries

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
  • Edit
Structured Polymers
ACQUISITION by Evonik Industries Feb 2019
SurModics
BUYOUT by GTCR May 2024
Dr. Straetmans
ACQUISITION by Evonik Industries Mar 2017
Alkion Biopharma
ACQUISITION by Evonik Industries May 2016
Monarch catalyst Pvt. Ltd.
ACQUISITION by Evonik Industries Jun 2015
View 22 more